Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
Cabazitaxel with Abiraterone versus Abiraterone Alone Randomized Trial for Extensive Disease Following Docetaxel: The CHAARTED2 Trial
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Bendamustine and Rituximab (BR) Alone Versus in Combination with Acalabrutinib (ACP-196) in Subjects with Previously Untreated Mantle Cell Lymphoma
Study Type: Treatment
Phase: III
NCTID: NCT02972840
Principal Investigator:
Marc Hoffmann
A Phase III, Global, Multi-Center, Double-Blind, Randomized, Efficacy Study of Zolbetuximab IMAB362 Plus CAPOX Compared with Placebo Plus CAPOX as First-line Treatment of Subjects with Claudin CLDN18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction GEJ Adenocarcinoma
Phase II Trial of Tremelimumab in Patients with Metastatic Urothelial Cancer Previously Treated with PD-1/PD-L1 Blockade
A Multicenter Study of 5-Aminolevulinic Acid 5-ALA to Enhance Visualization of Malignant Tumor in Patients with Newly Diagnosed or Recurrent Malignant Gliomas: A Safety, Histopathology, and Correlative Biomarker Study
vGRID SBRT: A Phase I Clinical Trial in Unresectable HCC
A Randomized, Double-blind, Placebo-controlled Phase III Trial of Pembrolizumab MK-3475 Versus Placebo in Participants with Esophageal Carcinoma Receiving Concurrent Definitive Chemoradiotherapy KEYNOTE 975
Effectiveness of the SpaceOAR Vue System in Subjects with Prostate Cancer being Treated with Stereotactic Body Radiotherapy SABRE
Study Type: Prevention
Phase: N/A
NCTID: NCT04905069
Principal Investigator:
Ronald Chen